Recipient Organization
ZYMOCHEM INC
4 ANCHOR DR STE 231
EMERYVILLE,CA 94608
Performing Department
(N/A)
Non Technical Summary
1-Hexanol has a global market size of ~200,000 MT/yr, wherein this alcohol is used as an endproduct or as an intermediate in producing other industrial chemicals with applications in the plastics, textile, perfume, and chemicals industries. 1-Hexanol is commercially produced from petrochemicalsvia processes the require substantial energy inputs, use toxic gases, and waste that is difficult to dispose of. Suffice to say, current approaches for making 1-hexanol are neither sustainable nor environmentally friendly.Microbial processes are a promising,sustainable alternative to petroleum-based approaches for making chemicals such as 1-hexanol. However, most of today's processes for the biological production of chemicals are simply not as carbon efficient. These inefficiencies are namely due to theto loss of ~33% of the sugar's carbon as carbon dioxide waste(CO2), which causes an increase in production costs and results in bioprocesses that are economically disadvantaged- arguably the most crucial factor for commercializing technology to produce chemicals. Thus, there is a clear need within the chemicals industry to develop bio-based renewable processes with improved yields, better economics, smaller environmental footprints, and greater sustainability than existing petroleum-based processes.We are developing a platform of enzyme-based pathways for converting renewable feedstocks such as corn-stover & woody biomass into chemicals, where essentially noneof the sugar's carbon is lost as CO2. Our"carbon-conserving" (C2) pathwaysenable microbes to make chemicals like 1-hexanol with improved theoretical yieldsand more economically compared to state-of-the-art approaches. During the previous Phase I project, we confirmedthe technical feasibility of our novel enzyme-based C2 pathway. In Phase II, we aim to integrate this C2 pathway into an engineered & optimizedindustrially-relevant microorganism with a robustability to produce1-hexanol from sugars, which will allow us to transition to larger scales for developing the entire bio-based processto make 1-hexanol.The commercialization of our C2 technology for producing1-hexanol will have several broad-reaching benefits such as alleviating dependence on foreign oil, decreasing adverse environmental consequences of current processes, and promoting sustainable manufacturing. Successful completion of our project will also provide a new foundation for sustainable industrial chemicals as well as diversify the use of agricultural and forest feedstocks. Doing so will create new markets for agricultural and rural businesses, thereby expanding economic opportunities and creating jobs in the renewable energy/chemicals sector.
Animal Health Component
80%
Research Effort Categories
Basic
(N/A)
Applied
80%
Developmental
20%
Goals / Objectives
Our primary technical objective for our priorPhase I project was to establish the feasibility of our carbon-conserving (C2) pathway for making 1-hexanolin vitrostarting from the initial substrates.During Phase I, we discovered and/or confirmed enzymes that catalyze all nine steps in the C2pathway for producing 1-hexanol and validated the pathway's functionality by demonstrating cell-free synthesis of 1-hexanol. We also carried out preliminary studies toward constructing the C2pathway for themicrobial production of 1-hexanol, confirming the in vivofunctionality of sections of the C2pathway.For this Phase II project, we have two high-level technical goals with multiple milestones and associated metrics to track progress toward completing the two objectives.Objective #1 -In vivovalidation of the C2 pathway by illustrating its functionality in an industrially relevant microorganism for converting the Step #1 substrates to 1-hexanol.Objective #2 -Engineering production strains and optimizing the C2 pathway toward improving 1-hexanol production metrics (increased titers, productivities, and yield) that will justify transitioning to pilot scale R&D.
Project Methods
Our work plan involvesof several tasks to achieve the milestones we have laid outto complete the two high-levels goalsfor this project. The overall work flow will consist of (but not be limited to) bioprospecting, high-throughputin vitroenzyme characterization & development, strain engineering via chromosomeediting, recombinant DNA synthesis,metabolic engineering & pathway construction, anaerobicin vivocell culture work, -omics studies,use of analytics,lab-scale bioreactor studies, and downstream process development toward product recovery.